![Richard Christopher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Christopher
Vorstandsvorsitzender bei
LEXARIA BIOSCIENCE CORP.
Vermögen: 39 130 $ am 31.05.2026
Profil
Mr. Richard C.
Christopher is a Chief Executive Officer & Director at Lexaria Bioscience Corp.
He is on the Board of Directors at Lexaria Bioscience Corp.
Mr. Christopher was previously employed as a Chief Financial Officer & Treasurer by Invivo Therapeutics Holdings Corp., a CFO, Secretary, Treasurer & Executive VP by iCAD, Inc., a Chief Operating & Financial Officer by Lucid, Inc., a Chief Financial Officer & Vice President-Finance by DUSA Pharmaceuticals, Inc., and a Manager-North American Cost Accounting by W.
R.
Grace & Co.-Conn.
He received his undergraduate degree from Bentley University and a graduate degree from Suffolk University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.12.2025 | 65’000 ( 0.26% ) | 39 130 $ | 31.05.2026 |
Aktive Positionen von Richard Christopher
| Unternehmen | Position | Beginn |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Vorstandsvorsitzender | 31.08.2024 |
Ehemalige bekannte Positionen von Richard Christopher
| Unternehmen | Position | Ende |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Finanzdirektor/CFO | 01.01.2024 |
| ICAD | Finanzdirektor/CFO | 11.01.2019 |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Finanzdirektor/CFO | 01.12.2016 |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Finanzdirektor/CFO | 01.04.2013 |
| W. R. GRACE & CO. | Comptroller/Controller/Auditor | 01.12.2000 |
Ausbildung von Richard Christopher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Health Technology |
W. R. Grace & Co.-Conn.
 W. R. Grace & Co.-Conn. Chemicals: Major DiversifiedProcess Industries Manufactures and markets chemical catalysts, absorbents & synthetic silicas | Process Industries |
Lexaria Bioscience Corp.
 Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
iCAD, Inc.
 iCAD, Inc. Packaged SoftwareTechnology Services Operates as an AI platform for cancer detection | Technology Services |
Caliber Imaging & Diagnostics, Inc.
 Caliber Imaging & Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures noninvasive diagnostic confocal imagers | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
Wählen Sie MarketScreener 
